CoChat

Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: Glucagon-like peptide-1 receptor agonists (GLP-1RA) have delayed gastric emptying properties; however, the impact on esophagogastroduodenoscopy (EGD) visualization is unknown. Objective: This study examines the impact of GLP-1RA use on EGD visualization and gastric content retention. Methods: This was a retrospective cohort study with matched controls. The primary endpoint was the odds of retained food documented during EGD. Secondary endpoints included incidence of lavage and need for repeat EGD due to poor visualization and were compared using Fisher exact test. Analyses were performed in R Studio. Results: There were 59 patients in the cohort prescribed a GLP-1RA with 118 matched controls. Food retention was documented with 4 patients (6.8%) in the GLP-1RA cohort versus 2 patients (1.7%) in the control group (odds ratio [OR] 4.22 [95% CI 0.87-20.34]). No difference was observed in the need for lavage during EGD or in the need for repeat EGD attributed to poor visualization. Conclusion and Relevance: This study addresses a previously uninvestigated question in clinical practice. GLP-1RA did not significantly increase odds of retained food on EGD. Although a numerical difference was observed, it did not reach statistical difference. No cases required repeat EGD due to poor visualization, and no change to EGD pre-procedure instructions were warranted at the study facility.

Overview

Integrity signals

Registry

Crossref · 10.1177/10600280211055804

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 5

  1. 10.1016/s0016-5107(03)80006. · doi:10.1016/s0016-5107(03)80006
  2. Keshavarzian Iber FL, 1987, Am J Gastroenterol, 82, 29
  3. 10.1002/(SICI)1096-9136(199602)13:2<112::AID-DIA37>3.0.CO. · doi:10.1002/(sici)1096-9136(199602)13:2<112::aid-dia37>3.0.co
  4. 10.1097/00004836-200401000. · doi:10.1097/00004836-200401000
  5. Fosso Quigley EMM, 2018, Gastroenterol Hepatol (N Y), 14, 140

Cited by

See all 77

Metadata

Authors
Stark, J. E., Cole, J. L., Ghazarian, R. N., & Klass, M. J.
Affiliations
Veterans Health Care System of the Ozarks (US)
Corresponding author
Stark, Jennifer E.
Venue
Annals of Pharmacotherapy
Published
2021-11-02
Volume
56
Issue
8
Pages
922-926
ISSN
  • 0012-6578 (ISSN-L)
  • 1060-0280
  • 1542-6270
OpenAlex
W3209867958
Cited by
77
References
8
Citations by year
2026: 12 · 2025: 24 · 2024: 35 · 2023: 6
FWCI
7.64
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Annals of Pharmacotherapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
GLP-1 receptor agonists, upper gastrointestinal endoscopy, gastric emptying, lavage, antidiabetic drugs
MeSH terms
Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Retrospective Studies, Endoscopy, Digestive System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD). https://app.cochat.ai/papers/10.1177/10600280211055804
The paper
Stark, J. E., Cole, J. L., Ghazarian, R. N., & Klass, M. J. (2022). Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD). Annals of Pharmacotherapy. https://doi.org/10.1177/10600280211055804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.